Page last updated: 2024-09-04

carbapenems and oxytocin, asp(5)-

carbapenems has been researched along with oxytocin, asp(5)- in 3 studies

Compound Research Comparison

Studies (carbapenems)	Trials (carbapenems)	Recent Studies (post-2010) (carbapenems)	Studies (oxytocin, asp(5)-)	Trials (oxytocin, asp(5)-)	Recent Studies (post-2010) (oxytocin, asp(5)-)
7,355	147	5,277	15	0	6

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Esterly, JS; Malczynski, M; Qi, C; Scheetz, MH	1
Karah, N; Samuelsen, Ø; Sundsfjord, A; Towner, K	1
Al Johani, SM; Al Salman, J; Al-Abri, S; Al-Jardani, A; Alfaresi, M; AlJindan, RY; Balkhy, HH; Dashti, AA; Ibrahim, E; Kutbi, AH; Paterson, DL; Sartor, AL; Schlebusch, S; Sidjabat, HE; Walsh, TR; Zowawi, HM	1

Reviews

1 review(s) available for carbapenems and oxytocin, asp(5)-

Article	Year
Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2012, Volume: 15, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Molecular Epidemiology; Oxytocin	2012

Article

Year

Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2012, Volume: 15, Issue:4

Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Molecular Epidemiology; Oxytocin

2012

Other Studies

2 other study(ies) available for carbapenems and oxytocin, asp(5)-

Article	Year
Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and bla OXA gene status. Pharmacotherapy, 2010, Volume: 30, Issue:4 Topics: Acinetobacter baumannii; beta-Lactamases; Carbapenems; Doripenem; Genotype; Hospitals; Humans; Imipenem; Meropenem; Oxytocin; Polymerase Chain Reaction; Thienamycins	2010
Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle East; Oxytocin	2014

Article

Year

Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and bla OXA gene status.

Pharmacotherapy, 2010, Volume: 30, Issue:4

Topics: Acinetobacter baumannii; beta-Lactamases; Carbapenems; Doripenem; Genotype; Hospitals; Humans; Imipenem; Meropenem; Oxytocin; Polymerase Chain Reaction; Thienamycins

2010

Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers.

Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle East; Oxytocin

2014